Korman NJ, Passeron T, Gordon KB, Okubo Y, Bagel J, Sofen H, Warren RB, Bhatia N, Spelman L, Winthrop K, Hippeli L, Kisa RM, Banerjee S, Thaçi D. Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. J of Skin [Internet]. 2023 Mar. 13 [cited 2024 Jul. 4];7(2):s119. Available from: https://jofskin.org/33014/index.php/skin/article/view/1981